Team Member: Matt Hansen

  • Behavioral Health Market Pulse – March 2026

    Behavioral Health Market Pulse – March 2026

    Northborne Partners is pleased to announce the release of its Digital Behavioral Health Market Pulse. This report provides strategic insights into the rapidly evolving ecosystem for both providers and patients. For providers, a workflow revolution of AI and data analytics, which is directly improving provider throughput, patient engagement and clinical decision making and outcomes. For patients, specifically focusing on the transition from traditional “sick care” to Preventative Whole Health platforms and the technology enabling this transformation.

    Strategic industry Trends

    • From “Sick Care” to Preventative Whole Health: The market is witnessing a fundamental shift from reactive, crisis-based response to proactive, preventative models. Early identification and continuous monitoring are now strategic priorities for payers and providers looking to manage chronic conditions before they escalate.
    • AI-Driven Efficiency & Outcomes: AI-native clinical tools – including ambient documentation, virtual agents and automated screening – are allowing providers to handle higher patient volumes while reducing administrative burnout.
    • Integrated Ecosystems: Solutions are no longer “point products.” Success is now measured by the ability to offer a personalized, integrated solutions that connect data and insights with medical therapies.

    What You Will Find in the Report

    • Detail on Trends Shaping the Segment
    • Investor Appetite in Today’s Environment
    • Company Landscape within the Digital Segment
    • M&A Volume and Trends
    • Public and Private Capital Markets Update

    Northborne Partners remains highly active in the Behavioral Health and Digital Health sector. Our perspectives are grounded in active advisory mandates and an ongoing dialogue with strategic buyers, private equity investors and key figures in the industry.

  • Medical Device Manufacturing Market Pulse

    Medical Device Manufacturing Market Pulse

    Northborne Partners is pleased to announce the release of its Medical Device Manufacturing Market Pulse. This report provides updated insight into the following areas of medical device manufacturing:

    • Latest CDMO M&A Trends and Drivers
    • OEM Performance and Sentiment
    • Segment Highlights: Catheters and Nitinol
    • Market Size and Segmentation
    • Industry Landscape and Key Players
    • Contract Manufacturing Benchmarking

    Northborne Partners continues to see demand for medical device contract manufacturers despite a challenging 2023 and 2024. Our ongoing dialogue with relevant contract manufacturing executives, owners, and Medical Device OEMs provides plenty of reasons for optimism in 2H 2025 and throughout 2026.

  • Medical Manufacturing Update 2025

    Medical Manufacturing Update 2025

    Northborne Partners is pleased to announce the release of its Medtech Market Pulse. This report provides insight into the following areas of medical device manufacturing:

    • Impact of New Presidential Administration Policy Changes
    • OEM Performance and Sentiment
    • OEM Challenges and Opportunities
    • Market Size and Segmentation
    • Industry Landscape and Key Players
    • Overview of Private Equity Interest and Activity

    Northborne Partners remains active in medical device manufacturing and broader MedTech. Our perspectives are based on M&A advisory experience and ongoing dialogue with relevant OEMs, contract manufacturing executives, suppliers, and industry consultants.

  • Medical Manufacturing Spotlight – Orthopedics

    Medical Manufacturing Spotlight – Orthopedics

    Northborne Partners is pleased to announce the release of its Orthopedic Segment Spotlight. This report provides insight into the following areas of orthopedic device manufacturing:

    • Key Themes Shaping 2024 and Beyond
    • Market Size and Market Share Within the Segment
    • Value drivers that influence company-specific transaction multiples
    • Industry landscape and Key Players

    Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We have compiled our spotlight based on real-time experience representing multiple clients in the space and conversations with leading industry participants and executives.

  • 2024 Precision Medical Manufacturing Outlook

    2024 Precision Medical Manufacturing Outlook

    Northborne Partners is pleased to provide a recap of 2024 MD&M West in Anaheim, CA. This brief provides insight into:

    • Recap of MD&M West
    • CDMO Opportunities
    • Strategic M&A Activity & Appetite
    • Emerging Segment of Interest

    Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We hosted numerous meetings with business owners, strategic acquirers and private equity investors at MD&M West to maintain our pulse on what matters on both sides of the aisle.

  • 2023 Review and 2024 Precision Medical Manufacturing Outlook

    2023 Review and 2024 Precision Medical Manufacturing Outlook

    Northborne Partners is pleased to announce the release of its 2023 Precision Medical Manufacturing Review and 2024 Outlook. This detailed report provides insight into the following areas of medical contract manufacturing:

    • Key learnings from 2023
    • Historical sector M&A activity and valuations
    • Value drivers that influence company-specific transaction multiples
    • Industry landscape and active acquirors

    Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We have compiled our 2024 outlook based on real-time experience representing multiple clients in the space and conversations with leading industry participants and executives.